DCT

1:20-md-02930

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

General
Filed
03/27/20
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
SourcePACER
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
03/15/22 - now
36%
03/31/20 - 03/15/22
41%